# US 2024/0293816 A1 · Device having horizontal nanochannel for nanopore sequencing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0293816 A1
- Document ID: US20240293816A1
- Status: Published application
- Kind: A1
- Application number: 18/574,214
- Filed: 2022-06-30
- Published: 2024-09-05
- Earliest claimed: 2021-07-01
- Assignees: Illumina, Inc.
- Applicants: Illumina, Inc.
- Inventors: Rean Silke Musa; Anthony Flannery; Boyan Boyanov; Nigel COBURN; Sharis MINASSIAN
- Web page: https://patentgrep.com/patent/US20240293816A1

## CPC

- B01L 3/502761: {specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules}
- G01N 27/4145: {specially adapted for biomolecules, e.g. gate electrode with immobilised receptors}
- C12Q 1/6869: Methods for sequencing
- G01N 33/48721: {Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68)}
- B01L 2300/0645: Electrodes
- B01L 2300/0829: Multi-well plates; Microtitration plates
- B01L 2300/0893: having a very large number of wells, microfabricated wells
- B01L 2400/0427: Electrowetting
- B01L 2400/046: Chemical or electrochemical formation of bubbles
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Devices for sequencing biopolymers, methods of manufacturing the devices, and methods of using the devices are disclosed. In one example, such a device has a nanopore and a horizontal nanochannel. In some embodiments, the horizontal nanochannel may take a tortuous path. In some embodiments, such a device includes gas or air bubble generators or pressure pulse generators to block or unblock the horizontal nanochannel.

## Claims

### Claim 1

A nanopore sequencing device, comprising:
a substrate comprising a dielectric layer and at least one sensing electrode on a surface of the dielectric layer;
a cis well associated with a cis electrode;
a trans well associated with a trans electrode;
a middle well associated with the sensing electrode and positioned on the substrate, wherein the middle well is positioned on the substrate and in fluid communication with the cis well and the trans well;
a nanopore fluidically connecting the cis well and the middle well; and
a nanochannel fluidically connecting the middle well and the trans well, wherein the nanochannel is formed on the surface of the substrate.

### Claim 2 (depends on 1)

The nanopore sequencing device of claim 1, wherein the nanochannel does not comprise a through-hole in the substrate.

### Claim 3 (depends on 1)

The nanopore sequencing device of claim 1, wherein the nanopore is positioned in and through a membrane separating the cis well and the middle well.

### Claim 4 (depends on 3)

The nanopore sequencing device of claim 3, wherein the membrane is formed of lipid, silicon, graphene, a solid-state material, a synthetic material, a biomimetic equivalent of lipid, or any combination thereof.

### Claim 5 (depends on 3)

The nanopore sequencing device of claim 3, wherein the nanopore is a hollow in a structure formed of one or more polynucleotides, one or more polypeptides, one or more types of biopolymers, one or more carbon nanotubes, one or more types of solid-state materials, or any combination thereof disposed in the membrane.

### Claim 6 (depends on 1)

The nanopore sequencing device of claim 1, wherein the nanopore comprises biologically derived material.

### Claim 7 (depends on 6)

The nanopore sequencing device of claim 6, wherein the nanopore comprises a porin.

### Claim 8 (depends on 1)

The nanopore sequencing device of claim 1, wherein the nanopore comprises non-biologically derived material.

### Claim 9 (depends on 1)

The nanopore sequencing device of claim 1, wherein at least the cis well or the trans well is positioned horizontally side-by-side with the middle well.

### Claim 10 (depends on 9)

The nanopore sequencing device of claim 9, wherein both the cis well and the trans well are positioned horizontally side-by-side with the middle well.

### Claim 11 (depends on 9)

The nanopore sequencing device of claim 9, wherein the cis well is positioned horizontally side-by-side with the middle well, and the trans well is positioned vertically adjacent to the middle well.

### Claim 12 (depends on 9)

The nanopore sequencing device of claim 9, wherein the trans well is positioned horizontally side-by-side with the middle well, and the cis well is positioned vertically adjacent to the middle well.

### Claim 13 (depends on 1)

The nanopore sequencing device of claim 1, wherein the middle well has a characteristic width of about 5 μm to about 200 μm.

### Claim 14 (depends on 1)

The nanopore sequencing device of claim 1, wherein the middle well has a characteristic depth of about 5 μm to about 200 μm.

### Claim 15 (depends on 1)

The nanopore sequencing device of claim 1, wherein the cis well has a characteristic width of about 10 μm to about 10 mm.

### Claim 16 (depends on 1)

The nanopore sequencing device of claim 1, wherein the trans well has a characteristic width of about 10 μm to about 10 mm.

### Claim 17 (depends on 1)

The nanopore sequencing device of claim 1, wherein the nanochannel has a tortuous path.

### Claim 18 (depends on 17)

The nanopore sequencing device of claim 17, wherein the tortuous path comprises a rectangular wave shape, a sine wave shape, a sawtooth shape, a zigzag shape, a spiral shape, or any combination thereof.

### Claim 19 (depends on 1)

The nanopore sequencing device of claim 1, wherein the nanochannel has a path length that is chosen to achieve a desired fluidic, ionic, and/or electrical resistance.

### Claim 20 (depends on 1)

The nanopore sequencing device of claim 1, wherein the nanochannel is about 5 nm to about 200 nm wide.

### Claim 21 (depends on 1)

The nanopore sequencing device of claim 1, wherein the nanochannel has a footprint with a length of between about 5 μm and about 500 μm.

### Claim 22 (depends on 21)

The nanopore sequencing device of claim 21, wherein the path length of the nanochannel is about 1.5 to about 50 times the length of the nanochannel footprint.

### Claim 23 (depends on 1)

The nanopore sequencing device of claim 1, further comprising at least one bubble generator, at least one pressure pulse generator, or any combination thereof to control a liquid flow in at least one of the second nanoscale openings.

### Claim 24 (depends on 1)

The nanopore sequencing device of any of claim 1, further comprising:
a plurality of middle wells, wherein each middle well is associated with a respective sensing electrode;
each middle well is in fluid communication with the cis well through a respective nanopore; and
each middle well is in fluid communication with the trans well through a respective nanochannel, wherein the respective nanochannel is oriented parallel to the substrate surface.

### Claim 25 (depends on 24)

The nanopore sequencing device of claim 24, wherein the respective nanopore is positioned in and through a respective membrane separating each of the middle wells and the cis well.

### Claim 26 (depends on 24)

The nanopore sequencing device of claim 24, wherein the trans well is a common trans channel in fluid communication with the plurality of middle wells through respective nanochannels.

### Claim 27 (depends on 24)

The nanopore sequencing device of claim 24, wherein the cis well is a common cis channel in fluid communication with the plurality of middle wells through respective nanopores.

### Claim 28 (depends on 24)

The nanopore sequencing device of claim 24, wherein the middle wells are arranged in an ordered array.

### Claim 29 (depends on 24)

The nanopore sequencing device of claim 24, wherein the device comprises at least 1,000,000 middle wells.

### Claim 30 (depends on 24)

The nanopore sequencing device of claim 24, wherein the device further comprises a gas bubble generator configured to generate a gas bubble to modulate or block a flow of current, ions, and/or fluid in the respective nanochannel.

### Claim 31 (depends on 30)

The nanopore sequencing device of claim 30, wherein the gas bubble generator comprises the respective sensing electrode configured to generate the gas bubble vis electrolysis.

### Claim 32 (depends on 30)

The nanopore sequencing device of claim 30, wherein the gas bubble generator comprises an electrode on the bottom of the nanochannel configured to generate the gas bubble via electrolysis or electrode wetting.

### Claim 33 (depends on 30)

The nanopore sequencing device of claim 30, wherein the gas bubble generator comprises a resistive heater underneath the nanochannel configured to generate the gas bubble.

### Claim 34 (depends on 30)

The nanopore sequencing device of claim 30, further comprises a gas bubble annihilator.

### Claim 35 (depends on 34)

The nanopore sequencing device of claim 34, wherein the gas bubble annihilator comprises an actuator or a piezoelectric element.

### Claim at position 36

36-68. (canceled)
